147 related articles for article (PubMed ID: 11008201)
21. Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast.
Marchiò C; Iravani M; Natrajan R; Lambros MB; Savage K; Tamber N; Fenwick K; Mackay A; Senetta R; Di Palma S; Schmitt FC; Bussolati G; Ellis LO; Ashworth A; Sapino A; Reis-Filho JS
J Pathol; 2008 Aug; 215(4):398-410. PubMed ID: 18484683
[TBL] [Abstract][Full Text] [Related]
22. The extent of proliferative and apoptotic activity in intraductal and invasive ductal breast carcinomas detected by Ki-67 labeling and terminal deoxynucleotidyl transferase-mediated digoxigenin-11-dUTP nick end labeling.
Shen KL; Harn HJ; Ho LI; Yu CP; Chiu SC; Lee WH
Cancer; 1998 Jun; 82(12):2373-81. PubMed ID: 9635530
[TBL] [Abstract][Full Text] [Related]
23. Widespread chromosomal abnormalities in high-grade ductal carcinoma in situ of the breast. Comparative genomic hybridization study of pure high-grade DCIS.
Moore E; Magee H; Coyne J; Gorey T; Dervan PA
J Pathol; 1999 Mar; 187(4):403-9. PubMed ID: 10398098
[TBL] [Abstract][Full Text] [Related]
24. p53 missense mutations in microdissected high-grade ductal carcinoma in situ of the breast.
Done SJ; Eskandarian S; Bull S; Redston M; Andrulis IL
J Natl Cancer Inst; 2001 May; 93(9):700-4. PubMed ID: 11333292
[TBL] [Abstract][Full Text] [Related]
25. [Evaluation of c-myc and CCNE2 amplification in breast cancer with quantitative multi-gene fluorescence in-situ hybridization].
Li Z; Meng Q; Yu Q; Zhou Z; Li L
Zhonghua Bing Li Xue Za Zhi; 2014 Jul; 43(7):455-8. PubMed ID: 25327794
[TBL] [Abstract][Full Text] [Related]
26. Amplification of growth regulatory genes in intraductal breast cancer is associated with higher nuclear grade but not with the progression to invasiveness.
Glöckner S; Lehmann U; Wilke N; Kleeberger W; Länger F; Kreipe H
Lab Invest; 2001 Apr; 81(4):565-71. PubMed ID: 11304576
[TBL] [Abstract][Full Text] [Related]
27. Detection of gene amplification in intraductal and infiltrating breast cancer by laser-assisted microdissection and quantitative real-time PCR.
Glöckner S; Lehmann U; Wilke N; Kleeberger W; Länger F; Kreipe H
Pathobiology; 2000; 68(4-5):173-9. PubMed ID: 11279343
[TBL] [Abstract][Full Text] [Related]
28. Correlation of HER2 gene amplification with expression of the apoptosis-suppressing genes bcl-2 and bcl-x-L in ductal carcinoma in situ of the breast.
Siziopikou KP; Khan S
Appl Immunohistochem Mol Morphol; 2005 Mar; 13(1):14-8. PubMed ID: 15722788
[TBL] [Abstract][Full Text] [Related]
29. Cyclin D1 overexpression in Algerian breast cancer women: correlation with CCND1 amplification and clinicopathological parameters.
Mohammedi L; Doula FD; Mesli F; Senhadji R
Afr Health Sci; 2019 Jun; 19(2):2140-2146. PubMed ID: 31656498
[TBL] [Abstract][Full Text] [Related]
30. Paget's disease of the nipple: a copy number of the genes ERBB2 and CCND1 versus expression of the proteins ERBB-2 and cyclin D1.
Mrhalova M; Kodet R
Neoplasma; 2003; 50(6):396-402. PubMed ID: 14689059
[TBL] [Abstract][Full Text] [Related]
31. Expression of c-erbB3 protein in primary breast carcinomas.
Naidu R; Yadav M; Nair S; Kutty MK
Br J Cancer; 1998 Nov; 78(10):1385-90. PubMed ID: 9823984
[TBL] [Abstract][Full Text] [Related]
32. Quantitative detection of amplification of proto-oncogenes in breast cancer.
Chen Y; Dong J; Lu Y; McGee JO
Chin Med J (Engl); 1995 Nov; 108(11):849-54. PubMed ID: 8585979
[TBL] [Abstract][Full Text] [Related]
33. 20q13.2 amplification in intraductal hyperplasia adjacent to in situ and invasive ductal carcinoma of the breast.
Werner M; Mattis A; Aubele M; Cummings M; Zitzelsberger H; Hutzler P; Höfler H
Virchows Arch; 1999 Nov; 435(5):469-72. PubMed ID: 10592049
[TBL] [Abstract][Full Text] [Related]
34. Comparison of HER2 amplification status among breast cancer subgroups offers new insights in pathways of breast cancer progression.
Lambein K; Van Bockstal M; Vandemaele L; Van den Broecke R; Cocquyt V; Geenen S; Denys H; Libbrecht L
Virchows Arch; 2017 Nov; 471(5):575-587. PubMed ID: 28567637
[TBL] [Abstract][Full Text] [Related]
35. Gene amplification of CCNE1, CCND1, and CDK6 in gastric cancers detected by multiplex ligation-dependent probe amplification and fluorescence in situ hybridization.
Ooi A; Oyama T; Nakamura R; Tajiri R; Ikeda H; Fushida S; Dobashi Y
Hum Pathol; 2017 Mar; 61():58-67. PubMed ID: 27864121
[TBL] [Abstract][Full Text] [Related]
36. [Her-2 amplification and p185 expression in invasive breast cancer cells in women].
Titi S
Ann Acad Med Stetin; 2006; 52(2):5-12. PubMed ID: 17633393
[TBL] [Abstract][Full Text] [Related]
37. Application of fine-needle aspiration to the demonstration of ERBB2 and MYC expression by in situ hybridization in breast carcinoma.
Soini Y; Mannermaa A; Winqvist R; Kamel D; Poikonen K; Kiviniemi H; Pääkkö P
J Histochem Cytochem; 1994 Jun; 42(6):795-803. PubMed ID: 7910618
[TBL] [Abstract][Full Text] [Related]
38. Detection of CCND1 , C-MYC , and FGFR1 amplification using modified SYBR Green qPCR and FISH in breast cancer.
Azarnezhad A; Tabrizi M; Javan F; Mehdipour P
Turk J Med Sci; 2018 Aug; 48(4):759-767. PubMed ID: 30119151
[TBL] [Abstract][Full Text] [Related]
39. c-erbB-2 overexpression and histological type of in situ and invasive breast carcinoma.
Somerville JE; Clarke LA; Biggart JD
J Clin Pathol; 1992 Jan; 45(1):16-20. PubMed ID: 1346789
[TBL] [Abstract][Full Text] [Related]
40. p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data.
O'Malley FP; Vnencak-Jones CL; Dupont WD; Parl F; Manning S; Page DL
Lab Invest; 1994 Jul; 71(1):67-72. PubMed ID: 8041120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
